Citations

Mayo Clinic

Showing 10 of 108551 citations.

Surgical Therapies and Tissue Engineering: At the Intersection Between Innovation and Regulation
Rubin, J. Peter, Gurtner, Geoffrey C. , March, Keith L. , Seppänen‐Kaijansinkko, Riitta , Yaszemski, Michael J. , Yoo, James J. , Liu, Wei Xin

Tissue Engineering Part A | February 19, 2016 | Volume: 22 | Issue: 5-6 | Pages: 397-400

10.1089/ten.tea.2016.0002 | PMID 26895615 Get It

Long-term clinical outcomes following 3- and 4-level anterior cervical discectomy and fusion
Ramos, Rafael De la Garza , Ramhmdani, Seba , Kosztowski, Thomas, Bydon, Mohamad , Sciubba, Daniel M. , Wolinsky, Jean‐Paul , Witham, Timothy F. , Gokaslan, Ziya L. , Bydon, Ali , Xu, Risheng , De la Garza Ramos, Rafael

Journal of Neurosurgery: Spine | February 19, 2016 | Volume: 24 | Issue: 6 | Pages: 885-891

10.3171/2015.10.spine15795 | PMID 26895527 Get It

OBJECTIVE The purpose of this study was to report the long-term clinical outcomes following 3- and 4-level anterior cervical discectomy and fusion (ACDF). METHODS A retrospective review of all adult neurosurgical patients undergoing elective ACDF for degenerative disease at a single institution between 1996 and 2013 was performed. Patients who underwent first-time 3- or 4-level ACDF were included; patients with previous cervical spine surgery, those undergoing anterior/posterior approaches, and those with corpectomy were excluded. Outcome measures included perioperative complication rates, fusion rates, need for revision surgery, Nurick Scores, Odom's criteria, symptom resolution, neck visual analog scale (VAS) pain score, and persistent narcotics usage. RESULTS Seventy-one patients who underwent 3-level ACDF and 26 patients who underwent 4-level ACDF were identified and followed for an average of 7.6 ± 4.2 years. There was 1 case (3.9%) of deep wound infection in the 4-level group and 1 case in the 3-level group (1.4%; p = 0.454). Postoperatively, 31% of patients in the 4-level group complained of dysphagia, compared with 12.7% in the 3-level group (p = 0.038). The fusion rate was 84.6% after 4-level ACDF and 94.4% after 3-level ACDF (p = 0.122). At last follow-up, a significantly higher proportion of patients in the 4-level group continued to have axial neck pain (53.8%) than in the 3-level group (31%; p = 0.039); the daily oral morphine equivalent dose was significantly higher in the 4-level group (143 ± 97 mg/day) than in the 3-level group (25 ± 10 mg/day; p = 0.030). Outcomes based on Odom's criteria were also different between cohorts (p = 0.044), with a significantly lower proportion of patients in the 4-level ACDF group experiencing an excellent/good outcome. CONCLUSIONS In this study, patients who underwent 4-level ACDF had significantly higher rates of dysphagia, postoperative neck pain, and postoperative narcotic usage when compared with patients who underwent 3-level ACDF. Pseudarthrosis and deep wound infection rates were also higher in the 4-level group, although this did not reach statistical significance. Additionally, a smaller proportion of patients achieved a good/excellent outcome in the 4-level group than in the 3-level group. These findings suggest a significant increase of perioperative morbidity and worsened outcomes for patients who undergo 4- versus 3-level ACDF.
Assessment of low-dose i.v. ketamine infusions for adjunctive analgesia
Kator, Sarah , Correll, Darin , Levinson, Radmila, Noronha, Genevieve N., Adams, Christopher , Ou, Judy Y.

American Journal of Health-System Pharmacy | February 19, 2016 | Volume: 73 | Issue: 5_Supplement_1 | Pages: S22-S29

10.2146/ajhp150367 | PMID 26896522 Get It

Impact of Electronic-Alerting of Acute Kidney Injury: Workgroup Statements from the 15 th ADQI Consensus Conference
Hoste, Eric A. J. , Wilson, F. Perry , Ronco, Claudio , Goldstein, Stuart L. , Bagshaw, Sean M. , Group, on behalf of the 15 ADQI Consensus, Kashani, Kianoush , Gibney, R. T. Noel , Kellum, John A. , Group, on behalf of the 15 ADQI Consensus, Wilson, F Perry , Ronco, Claudio , Bagshaw, Sean M

Canadian Journal of Kidney Health and Disease | February 19, 2016 | Volume: 3 | Issue: No issue available | Pages: No page available

10.1186/s40697-016-0101-1 | PMID 26925246 Get It

Purpose of the review: Among hospitalized patients, acute kidney injury is common and associated with significant morbidity and risk for mortality. The use of electronic health records (EHR) for prediction and detection of this important clinical syndrome has grown in the past decade. The steering committee of the 15 th Acute Dialysis Quality Initiative (ADQI) conference dedicated a workgroup with the task of identifying elements that may impact the course of events following Acute Kidney Injury (AKI) e-alert. Sources of information: Following an extensive, non-systematic literature search, we used a modified Delphi process to reach consensus regarding several aspects of the utilization of AKI e-alerts. Findings: Topics discussed in this workgroup included progress in evidence base practices, the characteristics of an optimal e-alert, the measures of efficacy and effectiveness, and finally what responses would be considered best practices following AKI e-alerts. Authors concluded that the current evidence for e-alert system efficacy, although growing, remains insufficient. Technology and human-related factors were found to be crucial elements of any future investigation or implementation of such tools. The group also concluded that implementation of such systems should not be done without a vigorous plan to evaluate the efficacy and effectiveness of e-alerts. Efficacy and effectiveness of e-alerts should be measured by context-specific process and patient outcomes. Finally, the group made several suggestions regarding the clinical decision support that should be considered following successful e-alert implementation. Limitations: This paper reflects the findings of a non-systematic review and expert opinion. Implications: We recommend implementation of the findings of this workgroup report for use of AKI e-alerts.
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia
Elala, Yoseph, Gangat, Naseema , Finke, Christy M. , Barraco, Daniela , Haider, Mahnur , Hussein, Ahmed Kamel Abou, Hanson, Curtis A. , Ketterling, Rhett P. , Pardanani, Animesh , Tefferi, Ayalew , Elala, Yoseph C, Lasho, Terra L. , Abou Hussein, Ahmed K, Ketterling, Rhett P

American Journal of Hematology | February 19, 2016 | Volume: 91 | Issue: 5 | Pages: 503-506

10.1002/ajh.24338 | PMID 26890983 Get It

About 85% of patients with essential thrombocythemia (ET) harbor one of three driver mutations: JAK2, calreticulin (CALR), and MPL; the remaining ( ∼15%) are wild type for all three mutations and are referred to as being “triple negative.” Furthermore, CALR mutations in ET are structurally classified as type 1/type 1‐like or type 2/type 2‐like variants. The objective of the current study was to examine the impact of CALR mutation variant stratified driver mutational status on overall (OS), myelofibrosis‐free (MFFS), thrombosis‐free, and leukemia‐free survival (LFS) in ET; 495 patients (median age 58 years; 61% females) with ET were fully annotated for the their driver mutational status: 321 (65%) harbored JAK2, 109 (22%) CALR, and 12 (2%) MPL mutations and 11% were triple‐negative. Among the 109 CALR‐mutated cases, 52% were classified as type 1/type 1‐like and 48% as type 2/type 2‐like. In univariate analysis, triple‐negative patients displayed the best and MPL mutated the worst OS (P = 0.007); however, the difference in OS was no longer apparent on multivariable analysis that included age and sex as covariates (P = 0.5). LFS was also similar among the different mutational groups (P = 0.6) whereas MFFS was significantly shorter in MPL‐mutated patients on both univariate and multivariable analyses (age‐adjusted P = 0.02; HR 7.9, 95% CI 2.0–31.5). Also in multivariable analysis that included thrombosis history, age, and cardiovascular risk factors, the presence of JAK2 or MPL mutations was independently associated with higher risk of thrombosis (P = 0.02; HR 1.9, 95% CI 1.1–3.4). In conclusion, driver mutational status in ET does not appear to influence overall or LFS, even after CALR variant stratification. However, the presence of MPL mutations might be associated with a higher risk of fibrotic transformation and the presence of JAK2/MPL mutations with higher risk of thrombosis. Am. J. Hematol. 91:503–506, 2016. © 2016 Wiley Periodicals, Inc.
Retrograde jejunogastric intussusception due to suture concretion
Fahy, Aodhnait S. , Nickerson, TP, Schiller, HJ

The Annals of The Royal College of Surgeons of England | February 18, 2016 | Volume: 98 | Issue: 03 | Pages: e45-e46

10.1308/rcsann.2016.0084 | PMID 26890849 Get It

We describe a patient who presented with acute small bowel obstruction five years after Roux-en-Y reconstruction. Computed tomography and operative exploration showed a retrograde intussusception at the gastrojejunostomy due to an intraluminal suture concretion. We describe the preoperative imaging, endoscopic and intraoperative findings, and review the literature.
Mayo Registry for Telemetry Efficacy in Arrest Study: An Assessment of the Utility of Telemetry in Predicting Clinical Decompensation
Snipelisky, David , Ray, Jordan , Matcha, Gautam , Roy, Archana , Bosworth, Veronica, Clark, Brooke, Vadeboncoeur, Tyler F. , Bowman, Cammi, Burton, M. Caroline , Harris, Dana, Dumitrascu, Adrian , Vadeboncoeur, Tyler, Harris, Dana M. , Kusumoto, Fred

Journal of Intensive Care Medicine | February 18, 2016 | Volume: 33 | Issue: 3 | Pages: 166-175

10.1177/0885066616631957 | PMID 26893319 Get It

Introduction: Our study assesses the utility of telemetry in identifying decompensation in patients with documented cardiopulmonary arrest. Methods: A retrospective review of inpatients who experienced a cardiopulmonary arrest from May 1, 2008, until June 30, 2014, was performed. Telemetry records 24 hours prior to and immediately preceding cardiopulmonary arrest were reviewed. Patient subanalyses based on clinical demographics were made as well as analyses of survival comparing patients with identifiable rhythm changes in telemetry to those without. Results: Of 242 patients included in the study, 75 (31.0%) and 110 (45.5%) experienced telemetry changes at the 24-hour and immediately preceding time periods, respectively. Of the telemetry changes, the majority were classified as nonmalignant (n = 50, 66.7% and n = 66, 55.5% at 24 hours prior and immediately preceding, respectively). There was no difference in telemetry changes between intensive care unit (ICU) and non-ICU patients and among patients stratified according to the American Heart Association telemetry indications. There was no difference in survival when comparing patients with telemetry changes immediately preceding and at 24 hours prior to an event (n = 30, 27.3% and n = 15, 20.0%) to those without telemetry changes during the same periods (n = 27, 20.5% and n = 42, 25.2%; P = .22 and .39). Conclusion: Telemetry has limited utility in predicting clinical decompensation in the inpatient setting.
Cardiac troponin in patients hospitalized with acute decompensated heart failure: A systematic review and meta‐analysis
Yousufuddin, Mohammed , Abdalrhim, Ahmed D., Murad, M. Hassan , Wang, Zhen , Murad, M Hassan

Journal of Hospital Medicine | February 18, 2016 | Volume: 11 | Issue: 6 | Pages: 446-454

10.1002/jhm.2558 | PMID 26889916 Get It

BACKGROUNDElevated cardiac troponin (cTn) is often observed in patients with acute decompensated heart failure (ADHF). We assessed the magnitude of association and quality of supporting evidence between cTn and clinically important outcomes in persons hospitalized for ADHF.METHODSWe searched MEDLINE In‐Process & Other Non‐Indexed Citations, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus from inception through February 28, 2015. The outcomes analyzed included hospital length of stay (LOS), readmissions, and mortality. Random effects meta‐analysis was used to combine outcomes across studies.RESULTSWe included 26 clinical studies. A detectable or elevated cTn was associated with increased LOS (odds ratio [OR]: 1.05; 95% confidence interval [CI]: 1.01‐1.10), increased in‐hospital mortality (OR: 2.57; 95% CI: 2.27‐2.91), and a composite of mortality and major adverse events (OR: 1.33; 95% CI: 1.03‐1.71) during hospitalization. ADHF patients with a detectable or elevated cTn were at increased risk for mortality and composite of mortality and readmission over the short term (mortality OR: 2.11; 95% CI: 1.43‐3.12; composite OR: 2.81; 95% CI: 1.60‐4.92), intermediate term (mortality OR: 2.21; 95% CI: 1.46‐3.35; composite OR: 2.30; 95% CI: 1.78‐2.99), and long term (mortality OR: 3.69; 95% CI: 2.64‐5.18; composite OR: 3.49; 95% CI: 2.08‐5.84). The overall confidence in estimates was moderate.CONCLUSIONSAmong ADHF patients, a detectable or elevated cTn identifies subjects at increased risk for adverse clinical outcomes during acute hospitalization and those at higher risk for postdischarge mortality and composite of readmission and mortality. Journal of Hospital Medicine 2016;11:446–454. 2016 Society of Hospital Medicine
Comment: Network disruption as a common framework for factors contributing to dementia
Jones, David T. , Jones, David Thomas

Neurology | February 18, 2016 | Volume: 86 | Issue: 12 | Pages: 1118-1118

10.1212/wnl.0000000000002504 | PMID 26888984 Get It

Dorsal horn circuitry
Benarroch, Eduardo E.

Neurology | February 18, 2016 | Volume: 86 | Issue: 11 | Pages: 1060-1069

10.1212/wnl.0000000000002478 | PMID 26888981 Get It